Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia-Reference-Cited by-同舟云学术

Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia

Published:2016-02-05 Issue:4 Volume:81 Page:742-752
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Dong Min¹,McGann Patrick T.²³,Mizuno Tomoyuki¹,Ware Russell E.²³,Vinks Alexander A.¹³

Affiliation:

1. Division of Clinical Pharmacology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

2. Division of Hematology; Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio

3. Department of Paediatrics; University of Cincinnati College of Medicine; Cincinnati Ohio USA

Funder

National Institutes of Health

Japan Research Foundation for Clinical Pharmacology

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12851/fullpdf

Reference35 articles.

1. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates;Piel;Lancet,2013

2. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell A, Follow-Up MSHP. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up;Steinberg;Am J Hematol,2010

3. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia;Charache;N Engl J Med,1995

4. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS);Voskaridou;Blood,2010

5. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG);Wang;Lancet,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fostering a healthier generation of children with sickle cell disease through advancements in care;Pediatric Research;2024-09-13

2. Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial;Acta Haematologica;2024-06-05

3. Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model‐Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell Anemia;Clinical Pharmacology & Therapeutics;2023-12-18

4. Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia;Blood Advances;2023-08-09

5. Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review;Pharmaceuticals;2023-06-08